arrow
A

Alan J. Korman

vir biotechnology
H指数:72
被引数:5.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling

Fc γ 受体的跨物种细胞定位和人源化以推进抗体建模

2026-01-300
PRE
Engineered ipilimumab variants that bind human and mouse CTLA-4

工程化改造的ipilimumab变体,可与人和小鼠CTLA-4结合

MABS
IF7.3
2025-01-240
OAAI
CD8+ T cell targeting of tumor antigens presented by HLA-E
2024-05-102
OAAI
Tim-3 mediates T cell trogocytosis to limit antitumor immunity

Tim-3介导T细胞胞吞作用以限制抗肿瘤免疫

2022-05-0231
OAAI
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression

去势介导的IL-8促进骨髓浸润和前列腺癌进展

2021-07-1966
OAAI
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

使用anti-CD137 Probody治疗剂的抗肿瘤功效和降低毒性

2021-06-2524
OA
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy (vol 10, pg 3850, 2019)
2020-11-262
OAAI
A conserved intratumoral regulatory T cell signature Identifies 4-1BB as a pan-cancer target
2020-02-0466
OA
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy (vol 10, 3850, 2019)
2020-01-303
OAAI
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
2019-08-28235
OAAI
DDR2 inhibition enhances response to anti-PD-1 immunotherapy
2019-07-010
PRE